Skip to main content

Table 3 Comparison between the studied groups as regard plasma PTX3 (ng/mL)

From: Pentraxin-3 in non-alcoholic fatty liver disease and its affection by concomitant chronic hepatitis C infection

Group

N

Mean ± SD

Range

Percentiles

p value between three groups

p value between groups I and II

25th

50th (median)

75th

Group Ι

 NAFLD patients

25

5.5 ± 4.9

0.3–20

2.5

4.0

6.6

< 0.001a

0.5b

Group ΙΙ

 NAFLD patients with HCV

25

5.8 ± 4.5

0.3–21

3.0

4.5

8.0

Group ΙΙΙ

 Healthy control

20

0.9 ± 0.5

0.2–2.1

0.5

0.9

1.2

  1. HCV hepatitis C virus, NAFLD nonalcoholic fatty liver disease
  2. aKruskal-Wallis test is statistically significant at 95% confidence level
  3. bMann-Whitney test is statistically significant at 95% confidence level